Cargando…
Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA
Influenza vaccine effectiveness varies annually due to the fast evolving seasonal influenza A(H3N2) strain and egg-derived mutations—both of which can cause a mismatch between the vaccine and circulating strains. To address these limitations, we have developed a hemagglutinin (HA)-based protein-dete...
Autores principales: | Portnoff, Alyse D., Patel, Nita, Massare, Michael J., Zhou, Haixia, Tian, Jing-Hui, Zhou, Bin, Shinde, Vivek, Glenn, Gregory M., Smith, Gale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157642/ https://www.ncbi.nlm.nih.gov/pubmed/32098409 http://dx.doi.org/10.3390/vaccines8010099 |
Ejemplares similares
-
2753. Induction of Broadly Cross-Reactive Immune Responses Against A(H3N2) Airuses: Results of a Phase 2 Trial of a Novel Recombinant Hemagglutinin Saponin-Adjuvanted Nanoparticle Seasonal Influenza Vaccine
por: Shinde, Vivek, et al.
Publicado: (2019) -
Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity
por: Patel, Nita, et al.
Publicado: (2020) -
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants
por: Logue, James, et al.
Publicado: (2023) -
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
por: Bajic, Goran, et al.
Publicado: (2019) -
Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice
por: Wang, Jiong, et al.
Publicado: (2018)